Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

[1]  Daniel Raftery,et al.  Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling. , 2014, Methods in molecular biology.

[2]  Erikka Loftfield,et al.  Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. , 2016, International journal of epidemiology.

[3]  Xifeng Wu,et al.  Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes , 2016, Oncotarget.

[4]  J. Dopazo,et al.  Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer , 2016, Oncotarget.

[5]  Dmitry L. Maslov,et al.  Mass spectrometric signatures of the blood plasma metabolome for disease diagnostics. , 2016, Biomedical reports.

[6]  R. Sinha,et al.  Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. , 2015, American journal of epidemiology.

[7]  Y. S. Park,et al.  Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy. , 2015, Surgical oncology.

[8]  J. Ajani,et al.  Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  C. la Vecchia,et al.  Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort , 2015, British Journal of Cancer.

[10]  S. Cuzzocrea,et al.  The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats. , 2015, European journal of pharmacology.

[11]  P. Bonomi,et al.  Treatment of advanced squamous cell carcinoma of the lung: a review. , 2015, Translational lung cancer research.

[12]  R. Sinha,et al.  Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. , 2015, The American journal of clinical nutrition.

[13]  Hongwei Li,et al.  Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer , 2015, BioMed research international.

[14]  Hongwei Li,et al.  Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry , 2015, Journal of Cancer Research and Clinical Oncology.

[15]  M. Daszykowski,et al.  Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. , 2014, Journal of pharmaceutical and biomedical analysis.

[16]  Dong Liang,et al.  The Ability of Bilirubin in Identifying Smokers with Higher Risk of Lung Cancer: A Large Cohort Study in Conjunction with Global Metabolomic Profiling , 2014, Clinical Cancer Research.

[17]  Daniel Raftery,et al.  Colorectal cancer detection using targeted serum metabolic profiling. , 2014, Journal of proteome research.

[18]  R. Henriksson,et al.  LRIG and cancer prognosis , 2014, Acta oncologica.

[19]  Joshua N Sampson,et al.  Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. , 2014, The American journal of clinical nutrition.

[20]  Song Liu,et al.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. , 2013, Translational oncology.

[21]  R. Scheff,et al.  Non–Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers , 2013, Seminars in Interventional Radiology.

[22]  M. Sawyer,et al.  Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus , 2012, World Journal of Surgical Oncology.

[23]  F. Sarkar,et al.  Metabolomics in cancer: a bench-to-bedside intersection. , 2012, Critical reviews in oncology/hematology.

[24]  Permender Rathee,et al.  In vitro anticancer activity of stachydrine isolated from Capparis decidua on prostate cancer cell lines , 2012, Natural product research.

[25]  Ivano Bertini,et al.  Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. , 2012, Cancer research.

[26]  E. Fukusaki,et al.  A metabolomic approach to lung cancer. , 2011, Lung cancer.

[27]  Florian Kronenberg,et al.  Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.

[28]  Takashi Daimon,et al.  Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study , 2010, BMC Cancer.

[29]  Oliver F Bathe,et al.  Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[30]  M. Sawyer,et al.  Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers , 2010, Clinical Cancer Research.

[31]  Jeremiah Stamler,et al.  Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. , 2010, Journal of clinical epidemiology.

[32]  D. Raftery,et al.  Early detection of recurrent breast cancer using metabolite profiling. , 2010, Cancer research.

[33]  E F Halpern,et al.  Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs. , 2010, Lung cancer.

[34]  J. Garcia-conde,et al.  Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups , 2010, Leukemia.

[35]  Wei Zou,et al.  Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. , 2010, Rapid communications in mass spectrometry : RCM.

[36]  T. Bathen,et al.  Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy , 2010, NMR in biomedicine.

[37]  Alexander G. Gray,et al.  Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines , 2009, BMC Bioinformatics.

[38]  Stefano Tiziani,et al.  Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. , 2009, Neoplasia.

[39]  Kyoungmi Kim,et al.  Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery*S , 2009, Molecular & Cellular Proteomics.

[40]  Wai-Nang Paul Lee,et al.  Nutrient-gene interaction: metabolic genotype-phenotype relationship. , 2005, The Journal of nutrition.

[41]  D. Hallahan,et al.  Nuclear survivin as a biomarker for non-small-cell lung cancer , 2004, British Journal of Cancer.

[42]  Keisuke Ito,et al.  Caffeine induces G2/M arrest and apoptosis via a novel p53‐dependent pathway in NB4 promyelocytic leukemia cells , 2003, Journal of cellular physiology.

[43]  M. Teh,et al.  Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore. , 2001, Carcinogenesis.

[44]  J. Sarkaria,et al.  Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. , 1999, Cancer research.

[45]  N. Saijo,et al.  In vitro Enhancement of Antitumor Activity of a Water‐soluble Duocarmycin Derivative, KW‐2189, by Caffeine‐mediated DNA‐repair Inhibition in Human Lung Cancer Cells , 1997, Japanese journal of cancer research : Gann.

[46]  D. Sidransky,et al.  Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase , 1996, Nature Medicine.

[47]  A. Papatestas,et al.  Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. , 1986, Surgery.